Rank: 20 (Previous rank: 38)
CEO: Robert Weiler
Headquarters: Waltham, MA
Revenue: $170.2 million
(four quarters to 12/31/08)
Return to investors: 8.69%
(three years to 12/81/08, annualized rate)
Phase Forward provides software that enables pharmaceutical, biotechnology, and medical device manufacturers to conduct clinical trials and drug safety tests more effectively. The World Economic Forum honored Phase Forward as a Technology Pioneer 2009, while the Dana-Farber/Harvard Cancer Center credited Phase Forward's software for helping reduce its data access times from eight weeks to real-time.
... What Readers Say
They speak out on the fastest-growing small public companies ...
|Executive||2008 Total Compensation
Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.
Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.
Factset: FactSet Research Systems Inc. 2014. All rights reserved.
Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.
Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.